These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5023983)
1. [Experience with contraceptive effect of Depo-Provera, 300mg and 450mg, administered in 6-month intervals]. Havránek F; Tichý M; Divila F; Hejda V Cesk Gynekol; 1972 Mar; 37(2):95-6. PubMed ID: 5023983 [TBL] [Abstract][Full Text] [Related]
2. [Our experiences with the use of contraceptive preparation Depo-Provera]. Bruchác D; Sklovský A Cesk Gynekol; 1972 Sep; 37(7):516-7. PubMed ID: 4562178 [TBL] [Abstract][Full Text] [Related]
3. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent. Jeppsson S Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161 [No Abstract] [Full Text] [Related]
4. [Use of Depo Provera as a contraceptive in the puerperium]. Narducci U; Piatti N Minerva Ginecol; 1973 Feb; 25(2):107-11. PubMed ID: 4735312 [TBL] [Abstract][Full Text] [Related]
5. [Studies on peripheral mechanism of action and compatibility with the parenteral contraceptive Depo-Clinovir (Depo-Provera)]. Hagen H; Steindel E; Drühl S; Behr W Dtsch Gesundheitsw; 1970 Aug; 25(34):1597-607. PubMed ID: 5503244 [No Abstract] [Full Text] [Related]
6. A field study of Depo-Provera: its use as a contraceptive method by women in a rural town in West Malaysia from February 1968 to December 1969. Hew Wai Sin ; Peng JY; Dato Ariffin Marzuki Med J Malaysia; 1973 Jun; 27(4):299-305. PubMed ID: 4270790 [TBL] [Abstract][Full Text] [Related]
7. Experience with Depo-provera as an injectable contraceptive. Schwallie PC J Reprod Med; 1974 Sep; 13(3):113-7. PubMed ID: 4413363 [No Abstract] [Full Text] [Related]
9. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. Harel Z; Biro FM; Kollar LM J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688 [TBL] [Abstract][Full Text] [Related]
10. Long-term contraception with Depo-Provera: a clinical evaluation. Mukherjea M; Mukherjee P; Biswas R Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of an injectable progestin-estrogen as a contraceptive. Scommegna A; Lee AW; Borushek S Am J Obstet Gynecol; 1970 Aug; 107(8):1147-55. PubMed ID: 4917852 [TBL] [Abstract][Full Text] [Related]
13. [Depo-provera as a long-term contraceptive]. Janaud A Contracept Fertil Sex (Paris); 1974 Mar; 2(2):95-104. PubMed ID: 12333651 [TBL] [Abstract][Full Text] [Related]
14. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Basnayake S; Thapa S Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188 [TBL] [Abstract][Full Text] [Related]
15. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. Harel Z; Biro FM; Kollar LM; Rauh JL J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083 [TBL] [Abstract][Full Text] [Related]
17. [Prolonged use of medroxyprogesterone acetate for contraception]. Pena Delgado J; Aleman Herrera M; Baez Reyes A Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435 [TBL] [Abstract][Full Text] [Related]
18. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive. Gardner JM; Mishell DR Fertil Steril; 1970 Apr; 21(4):286-91. PubMed ID: 5508497 [TBL] [Abstract][Full Text] [Related]